These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24401595)

  • 21. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative binding of dominant-negative prion protein to kringle domains.
    Ryou C; Prusiner SB; Legname G
    J Mol Biol; 2003 May; 329(2):323-33. PubMed ID: 12758079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological mimicry of PrPC-PrPSc interactions: antibody-induced PrP misfolding.
    Li L; Guest W; Huang A; Plotkin SS; Cashman NR
    Protein Eng Des Sel; 2009 Aug; 22(8):523-9. PubMed ID: 19602568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP.
    Munoz-Montesino C; Larkem D; Barbereau C; Igel-Egalon A; Truchet S; Jacquet E; Nhiri N; Moudjou M; Sizun C; Rezaei H; Béringue V; Dron M
    J Biol Chem; 2020 Oct; 295(41):14025-14039. PubMed ID: 32788216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells.
    Gomes MP; Millen TA; Ferreira PS; e Silva NL; Vieira TC; Almeida MS; Silva JL; Cordeiro Y
    J Biol Chem; 2008 Jul; 283(28):19616-25. PubMed ID: 18456654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
    Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
    Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M; Kato-Negishi M; Tanaka KI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward molecular dissection of PrPC-PrPSc interactions.
    Solforosi L; Bellon A; Schaller M; Cruite JT; Abalos GC; Williamson RA
    J Biol Chem; 2007 Mar; 282(10):7465-71. PubMed ID: 17218310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease-resistant prions selectively decrease Shadoo protein.
    Watts JC; Stöhr J; Bhardwaj S; Wille H; Oehler A; Dearmond SJ; Giles K; Prusiner SB
    PLoS Pathog; 2011 Nov; 7(11):e1002382. PubMed ID: 22163178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity.
    Harrison CF; Lawson VA; Coleman BM; Kim YS; Masters CL; Cappai R; Barnham KJ; Hill AF
    J Biol Chem; 2010 Jun; 285(26):20213-23. PubMed ID: 20356832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
    Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
    J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
    Yam AY; Gao CM; Wang X; Wu P; Peretz D
    PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.
    Dong CF; Wang XF; Wang X; Shi S; Wang GR; Shan B; An R; Li XL; Zhang BY; Han J; Dong XP
    Med Microbiol Immunol; 2008 Dec; 197(4):361-8. PubMed ID: 18087720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-assembly of recombinant prion protein of 106 residues.
    Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
    Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
    Davenport KA; Henderson DM; Mathiason CK; Hoover EA
    J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.